Hotchkis & Wiley Capital Management
MED icon

Hotchkis & Wiley Capital Management’s Medifast MED Stock Holding History

Hotchkis & Wiley Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-294,880
Closed -$5.2M – 493
2024
Q4 		$5.2M Hold
294,880
– – 0.02% 389
2024
Q3 		$5.64M Sell
294,880
-28,000
-9% -$540K 0.02% 386
2024
Q2 		$7.05M Buy
322,880
+34,510
+12% +$920K 0.02% 314
2024
Q1 		$11.1M Buy
288,370
+121,110
+72% +$5.87M 0.04% 218
2023
Q4 		$11.2M Buy
167,260
+32,740
+24% +$2.28M 0.04% 198
2023
Q3 		$10.1M Buy
134,520
+60,960
+83% +$5.41M 0.04% 200
2023
Q2 		$6.78M Buy
73,560
+16,680
+29% +$1.49M 0.03% 318
2023
Q1 		$5.9M Buy
56,880
+9,110
+19% +$1.01M 0.02% 330
2022
Q4 		$5.51M Buy
47,770
+10,450
+28% +$1.22M 0.02% 330
2022
Q3 		$4.04M Buy
37,320
+10,710
+40% +$1.53M 0.02% 354
2022
Q2 		$4.8M Buy
26,610
+430
+2% +$76.9K 0.02% 339
2022
Q1 		$4.47M Buy
26,180
+3,340
+15% +$630K 0.01% 386
2021
Q4 		$4.78M Buy
+22,840
New +$4.72M 0.02% 352
2020
Q3 		– Sell
-27,010
Closed -$3.75M – 469
2020
Q2 		$3.75M Sell
27,010
-9,960
-27% -$914K 0.02% 270
2020
Q1 		$2.31M Sell
36,970
-2,070
-5% -$188K 0.01% 325
2019
Q4 		$4.28M Buy
+39,040
New +$3.78M 0.01% 318

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Hotchkis & Wiley Capital Management's MED Position: Q1 2025 in Review

Hotchkis & Wiley Capital Management sold out of Medifast (MED) in Q1 2025, closing a stake of 294,880 shares — an estimated $5.2M sold.

Hotchkis & Wiley Capital Management first reported a position in MED in Q4 2019 and held it in 16 quarters. The position peaked at $11.2M in Q4 2023. 124 funds tracked by Wall St. Rank hold MED as of Q1 2025.

  • Hotchkis & Wiley Capital Management reported no remaining Medifast position as of Q1 2025 after selling out during the quarter.
  • Hotchkis & Wiley Capital Management sold 294,880 Medifast shares in Q1 2025, an estimated $5.2M.
  • Hotchkis & Wiley Capital Management first reported a position in Medifast in Q4 2019 and held it in 16 quarters.
  • Hotchkis & Wiley Capital Management's Medifast position peaked at $11.2M in Q4 2023.
  • 124 funds tracked by Wall St. Rank held Medifast as of Q1 2025.

Based on Hotchkis & Wiley Capital Management's 13F filing for Q1 2025, filed 14 May 2025.